Profile data is unavailable for this security.
About the company
Fuso Pharmaceutical Industries, Ltd. is a Japan-based company principally involved in the manufacture and sale of pharmaceuticals and medical equipment for medical purposes. The Company operates in two business segments. The Pharmaceuticals segment is involved in manufacture and sale of pharmaceutical products, including injectable drugs, which mainly focus on infusion solution, dialysis fluid for artificial kidney, as well as the manufacture and sale of medical equipment and instruments. The Real Estate segment is engaged in the leasing of real estate properties.
- Revenue in JPY (TTM)60.56bn
- Net income in JPY-3.29bn
- Incorporated1937
- Employees1.34k
- LocationFuso Pharmaceutical Industries Ltd1-7-10, Dosho-machi, Chuo-kuOSAKA-SHI 541-0045JapanJPN
- Phone+81 662316887
- Fax+81 669692341
- Websitehttps://www.fuso-pharm.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wakamoto Pharmaceutical Co Ltd | 7.79bn | 64.44m | 10.10bn | 286.00 | 156.18 | 0.8669 | 20.42 | 1.30 | 1.86 | 1.86 | 224.44 | 334.53 | 0.5121 | 1.65 | 2.89 | 27,235,880.00 | 0.4236 | -0.0678 | 0.4849 | -0.0781 | 46.50 | 48.65 | 0.8273 | -0.1246 | 2.88 | -- | 0.0085 | -- | 0.6595 | -6.53 | -40.86 | -- | 21.87 | -- |
| Solasia Pharma KK | 329.00m | -1.92bn | 10.13bn | 23.00 | -- | 10.46 | -- | 30.79 | -9.05 | -9.05 | 1.57 | 3.92 | 0.1634 | 1.17 | 13.16 | 14,304,350.00 | -95.58 | -64.46 | -140.54 | -80.79 | 57.75 | 59.35 | -584.80 | -401.81 | 2.51 | -- | 0.0195 | -- | -48.78 | -24.75 | -74.55 | -- | -73.26 | -- |
| RaQualia Pharma Inc | 3.42bn | -422.14m | 13.28bn | 85.00 | -- | 2.16 | 254.30 | 3.88 | -19.50 | -19.50 | 157.84 | 251.85 | 0.339 | 4.63 | 3.11 | 40,287,100.00 | -4.18 | 0.1792 | -4.79 | 0.1931 | 77.00 | 86.78 | -12.33 | 0.453 | 3.52 | -1.36 | 0.3781 | 0.00 | 63.45 | 12.78 | -52.95 | -- | 4.19 | -- |
| Stella Pharma Corp | 961.06m | -140.81m | 14.19bn | 43.00 | -- | 4.42 | -- | 14.77 | -4.51 | -4.51 | 28.79 | 94.26 | 0.2081 | 0.0983 | 2.43 | 22,350,190.00 | -3.05 | -16.41 | -3.36 | -18.19 | 88.00 | 87.03 | -14.65 | -176.16 | 10.28 | -31.18 | 0.1929 | -- | 256.62 | -- | 81.56 | -- | -21.34 | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.07bn | 718.00m | 14.48bn | 214.00 | 19.99 | 1.80 | 14.91 | 2.39 | 14.30 | 14.30 | 120.83 | 158.96 | 0.4822 | 1.51 | 3.32 | 28,341,120.00 | 5.71 | -- | 7.11 | -- | 58.47 | -- | 11.84 | -- | 2.66 | -- | 0.1694 | -- | 2.81 | -- | 124.87 | -- | -- | -- |
| CellSource Co Ltd | 3.95bn | -50.87m | 14.58bn | 157.00 | -- | 2.45 | 108.89 | 3.69 | -2.59 | -2.59 | 199.06 | 300.20 | 0.5714 | 7.53 | 11.54 | 25,145,820.00 | -0.7362 | 14.34 | -0.7931 | 16.24 | 51.01 | 66.97 | -1.29 | 17.33 | 11.17 | -20.93 | 0.00 | 15.92 | -3.45 | 22.00 | -74.22 | 3.58 | 58.82 | -- |
| Ohki Healthcare Holdings Co Ltd | 349.45bn | 2.64bn | 15.59bn | 648.00 | 5.73 | 0.4877 | 5.14 | 0.0446 | 193.46 | 193.46 | 25,617.06 | 2,271.84 | 2.51 | 12.56 | 4.87 | 539,277,800.00 | 1.90 | 1.77 | 7.62 | 7.74 | 5.30 | 5.26 | 0.7566 | 0.6977 | 0.8541 | -- | 0.3139 | 14.17 | 4.42 | 4.74 | 19.41 | 2.21 | 45.68 | 6.47 |
| Oncolys Biopharma Inc | 31.38m | -2.13bn | 15.95bn | 35.00 | -- | 8.18 | -- | 508.24 | -91.64 | -91.64 | 1.36 | 78.09 | 0.0141 | 0.00 | 0.1464 | 896,685.70 | -95.65 | -54.48 | -106.04 | -62.21 | 0.00 | 41.21 | -6,793.90 | -418.43 | 11.00 | -- | 0.1295 | -- | -50.21 | -52.54 | 13.09 | -- | -3.88 | -- |
| CellSeed Inc | 185.85m | -1.02bn | 17.06bn | 38.00 | -- | 9.65 | -- | 91.77 | -29.97 | -29.97 | 5.44 | 51.01 | 0.0807 | 1.93 | 9.65 | 4,890,895.00 | -44.45 | -45.50 | -48.94 | -49.29 | 54.52 | 57.47 | -550.92 | -478.14 | 6.69 | -1,101.08 | 0.074 | -- | 1.65 | -6.87 | -1.57 | -- | 6.39 | -- |
| StemRIM Inc | 0.00 | -1.97bn | 18.95bn | 44.00 | -- | 2.44 | -- | -- | -31.95 | -31.95 | 0.00 | 124.75 | 0.00 | -- | -- | 0.00 | -22.51 | -8.34 | -22.73 | -8.49 | -- | -- | -- | -68.74 | 102.85 | -- | 0.00 | -- | -100.00 | -- | -1,301.17 | -- | -4.35 | -- |
| Fuso Pharmaceutical Industries Ltd | 60.56bn | -3.29bn | 19.80bn | 1.34k | -- | 0.5415 | -- | 0.3269 | -385.05 | -385.05 | 7,089.56 | 3,869.04 | 0.7689 | 3.02 | 2.41 | 45,196,270.00 | -4.17 | 0.7682 | -7.85 | 1.29 | 27.30 | 26.94 | -5.43 | 1.05 | 0.7569 | 76.50 | 0.3918 | 106.29 | 9.31 | 5.25 | -338.78 | -- | 4.37 | 6.45 |
| Astena Holdings Co Ltd | 60.00bn | -1.94bn | 20.22bn | 1.42k | -- | 0.7678 | 53.08 | 0.337 | -48.34 | -48.34 | 1,490.42 | 640.83 | 0.9089 | 3.52 | 2.94 | 42,256,130.00 | -2.96 | 0.9596 | -5.35 | 1.72 | 35.11 | 27.66 | -3.26 | 0.9792 | 1.00 | -- | 0.3807 | 117.14 | 11.56 | -1.21 | -317.18 | -- | 16.43 | 6.72 |
| CanBas Co Ltd (Parent) | 0.00 | -1.49bn | 20.56bn | 11.00 | -- | 7.46 | -- | -- | -80.74 | -80.74 | 0.00 | 139.74 | 0.00 | -- | -- | 0.00 | -50.28 | -62.25 | -52.54 | -70.91 | -- | -- | -- | -2,015.62 | -- | -- | 0.00 | -- | -- | -- | 2.77 | -- | -- | -- |
| ReproCell Inc | 2.98bn | 103.25m | 21.43bn | 99.00 | 215.76 | 2.38 | 139.17 | 7.19 | 1.05 | 1.05 | 32.08 | 94.89 | 0.3182 | 5.13 | 6.73 | 30,087,140.00 | 1.10 | -4.09 | 1.19 | -4.47 | 55.36 | 43.75 | 3.47 | -13.66 | 7.22 | -- | 0.00 | -- | 22.74 | 19.94 | 428.65 | -- | -6.31 | -- |
Data as of Jul 14 2025. Currency figures normalised to Fuso Pharmaceutical Industries Ltd's reporting currency: Japanese Yen JPY
12.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 03 Jul 2025 | 264.90k | 2.80% |
| The Vanguard Group, Inc.as of 02 Jul 2025 | 236.71k | 2.51% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 15 Apr 2025 | 176.70k | 1.87% |
| Dimensional Fund Advisors LPas of 04 Jul 2025 | 151.40k | 1.60% |
| Nikko Asset Management Co., Ltd.as of 15 Apr 2025 | 113.50k | 1.20% |
| Daiwa Asset Management Co. Ltd.as of 30 May 2025 | 108.30k | 1.15% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 03 Jul 2025 | 46.60k | 0.49% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 26.81k | 0.28% |
| Dimensional Fund Advisors Ltd.as of 04 Jul 2025 | 23.02k | 0.24% |
| Vanguard Global Advisers LLCas of 31 May 2025 | 21.70k | 0.23% |
More ▼
Data from 31 Dec 2024 - 10 Jul 2025Source: FactSet Research Systems Inc.
